GSK’s $10.6B Nuvalent takeover fails to impress investors as shares fall: here's why (original) (raw)

Posted 2026-06-09, Invezz Headlines

GlaxoSmithKline is making its largest oncology acquisition in years with a $10.6 billion deal for US-based cancer drug developer Nuvalent, betting that a trio of promising lung cancer therapies can help drive future growth and offset looming patent expirations in its HIV portfolio. The acquisition, announced on Tuesday,...read full story

"Our strategy has been a brick-by-brick building approach,"

Ask about this article

Answer for your question of the article will be displayed here ...

Mizuho’s Jared Holz on GSK’s plan to acquire Nuvalent for $10.6 billion

CNBC 2026-06-09, 17:16

North Shore University Hospital Device Helps Wean Patients off Ventilator Faster

Business Wire 2026-06-09, 16:44

U.S. Stock Market prediction for Monday: Nasdaq, S&P 500, Dow Jones crash to continue in ...

The Economic Times 2026-06-08, 04:56

Dogs help uncover record haul of drugs hidden in lumber

CBS News
2026-06-09, 15:38

内田被告遺族の訴えに表情変えず

Yahoo Daily News
2026-06-08, 15:22

Dylan Harper hilariously described how he handled seeing Jay-Z before NBA Finals Game 3

Yahoo Daily News
2026-06-09, 18:57

Calidi Biotherapeutics Announces Investor Webinar on June 9, 2026

Nasdaq Globe Newswire
2026-06-08, 14:07

Marlins and Rays meet with series tied 1-1

The Associated Press
2026-06-07, 15:26

Young is co-Athlete of the Week

Kokomo Tribune
2026-06-09, 00:43

Why USMNT 1994 stars and present team can't get along: 'I’m going to be critical ...

The Athletic
2026-06-07, 20:26